A role for SUV39H1-mediated H3K9 trimethylation in the control of genome stability and senescence in WI38 human diploid lung fibroblasts

Results

Setup of the senescence model system WI-38

WI-38 human foetal lung fibroblasts have a limited in vitro lifespan of approximately 50 ± 10 PD [7, 8]. A cell stock obtained from ATCC at 19 PD was subcultured to reach three different passages (P10, P15, and P24). In order to determine the senescence status of those cells, we monitored their PD levels, their senescence ratios as determined by a flow cytometry-based SA-β-GAL assay, and their cell cycle distribution, as senescence is characterized by the permanent cell cycle arrest in the G1/G0 phase of the cell cycle as determined by the DNA amount per cell [26].

Along with the increasing PD level of the cell cultures, the P15 and P24 cultures contained a significantly higher ratio of senescent cells than the P10 cultures (Table 1). On the other hand, the cell cycle analysis revealed an initial increase in the number of cells in the G0/G1 phase along with a decrease in cells in the S or G2/M phases of the cell cycle, when comparing P15 to P10 cells (Table 1). When comparing P24 cells to P10 or P15 cells, a further decrease in S phase cells was observed, paralleled by a decrease in G1/G0 and an increase in G2/M cells (Table 1).

Table 1. Senescence properties of cell cultures

Population doubling (PD). G0/G1, S, and G2/M columns show the average percentage of cells in the given phase of the cell cycle ± standard deviation (SD). SA-β-Gal pos (%) shows the average percentage of SA-β-Gal positive cells ± SD.

Passage	PD	G0/G1	S	G2/M	SA-β-Gal pos (%)
P10	38.3 ± 0.6	73.6 ± 0.4	5.8 ± 0.7	20.7 ± 0.7	56.4 ± 7.1
P15	46.8 ± 0.3 *	77.6 ± 1.1 *	4.1 ± 0.4 *	18.4 ± 0.7 *	72.7 ± 4.5 *
P24	54.2 ± 0.1 *	71.9 ± 0.2 *	3.1 ± 0.1 *	25 ± 0.3 *	74.5 ± 1.8 *

However, as the determination of the cell cycle profile relies on the detection of the amount of DNA – half the amount of DNA in G1 when compared to G2 phase – it does not allow a distinction between tetraploid cells and G2 cells. Such an accumulation of large cells with altered ploidy levels as cultures became senescent has been described [26], and therefore the most accurate measure to compare the level of cell division in the different cell cultures may be given by the comparison of the number of cells in the S phase at each PD level.

Based on the significant increase in the senescence ratio of the P15 and P24 cultures along with the reduced ratio of cells in the S phase, these three cultures were chosen for all further experiments and will be referred to by their PD numbers (P10 as PD 38, P15 as PD 47, and P24 as PD 54).

Senescence-related changes to gene expression profiles are accompanied by changes in expression of transcriptional and epigenetic regulators

To obtain an understanding of what molecular pathways may be involved in the establishment of senescence or may be regulated during senescence, the gene expression profiles of the three different cultures (PD 38, PD 47, and PD 54) were determined using Illumina^® Gene Expression BeadChips (S1). Forty genes were differentially expressed when comparing PD 38 and PD 47 cultures, whereas 1,137 genes were differentially expressed between PD 38 and PD 54 (Fig. 1A). Of those genes, the majority were upregulated when comparing PD 47 to PD 38, whereas the majority were downregulated when comparing PD 54 to PD 38 (Fig. 1B). To understand the functional implications that these gene expression changes may have, they were classified by function (Fig. 1C, S2). Gene expression changes that occurred between PD 38 and PD 47 mainly affected apoptosis, but also transcriptional and epigenetic regulation. Changes that occurred between PD 38 and PD 54 mainly affected cell cycle regulation, but also DNA repair, apoptosis, and transcriptional and epigenetic regulation. Further, 80% of the genes that were differentially regulated between PD 38 and PD 47 were also differentially regulated between PD 38 and PD 54, which may indicate that these genes are involved early in the establishment of senescence and mainly play roles in cell signalling, apoptosis, and the modulation of the cytoskeleton and extra-cellular matrix (Fig. 1D). However, a few of the commonly deregulated genes are also involved in transcriptional or epigenetic regulation. This may indicate that changes in cellular signal transduction, as well as changes in transcriptional and epigenetic regulation, may be involved during the onset of cellular senescence.

Figure 1. Functional classification of the gene expression results.

(A) Total number of genes affected by expression changes when comparing PD 47 or PD 54 to PD 38 cells. (B) Number of genes with changed expression that were up- (light grey) or down-regulated (dark grey). (C) Functional classification of differentially expressed genes. (D) Functional classification of genes that were differentially expressed between PD 38 and PD 47 and between PD 38 and PD 54 cultures.

In addition to the cell cycle arrest of senescent cells in the G0/G1 phase [26], changes in gene expression patterns have been observed in various aging model systems [27]. Therefore, a differential expression of cell cycle regulators as well as senescence-associated genes would be expected in the cultures with higher PD levels. In order to test this, genes that were functionally classified to the cell cycle or aging categories were analyzed in more detail.

This showed differential expression of increasing fractions of genes involved in cell cycle regulation with increasing PD level (Fig. 1C,D); these genes were involved in the regulation of all stages of the cell cycle (S3). The largest group of genes was involved in the regulation of the progression of mitosis and these genes were mostly downregulated, indicating that mitosis occurred at a lower frequency in PD 54 than in PD 38 cultures. Further, most of the differentially expressed genes involved in DNA replication and all of the genes involved in regulation of S phase progression were downregulated, suggesting that DNA synthesis occurred at a lower frequency in the older cultures. Taken together, the observed gene expression changes indicate that high numbers of cells in PD 54 when compared to PD 38 are either in the G1/G0 or G2 phase of the cell cycle, supporting the cell cycle profile analysis (Table 1).

Further, age-related gene expression changes were observed in both PD 47 and PD 54 cultures compared to PD 38 cultures (Fig. 1C). These gene expression changes were compared to microarray information from the Human Ageing Genomic Resources and to the predicted functions of genes in aging or senescence (S4). Eleven out of the 16 genes presented were affected by expression changes corresponding to previously described age-related changes in expression [27]. The expression levels of several of these genes were confirmed by qRT-PCR (Fig. 2A,B).

Figure 2. Senescence-associated gene expression.

Transcript levels of COL3A1, POT1, and UBE2C (A), and E2F2 and FOXM1 (B). Averages of three biological and two technical replicates ± error progression of the SDs of the technical repeats.

In summary, among the genes that were differentially expressed in PD 54 cultures were numerous cell cycle regulators as well as genes with previously determined age-related expression changes. More detailed functional analysis of the cell cycle regulators and age-related gene expression changes supports the observation that cultures with higher PD levels contain higher numbers of senescent cells (Table 1). Thus, the subsequent step involved the investigation of the changes in the expression of transcriptional and epigenetic regulators in order to determine potential regulatory mechanisms underlying the senescence-associated changes in gene expression profiles.

A potential role of transcription factors in the establishment of senescence

The gene expression changes between PD 38 and PD 54 were extensive and included numerous transcription factors; further, a large regulatory network surrounding E2F1 could be detected in the dataset. E2F1 is a transcriptional activator involved in the regulation of G1/S progression and DNA replication [28]. Further, E2F1, E2F2, and E2F3 have been shown to interact with retinoblastoma (RB) protein during cell differentiation, resulting in the silencing of E2F target genes [29]. E2F1, E2F2 and E2F3 have been shown to modulate the expression of E2F target genes [28], but also play distinct roles [30]. Therefore, the observed transcriptional repression of E2F2 in the senescent cultures (Fig. 2B) may induce a shift in the regulation of E2F target genes and, at least in part, explain the differential expression of the genes in the regulatory network of E2F1.

Thus, it can be hypothesized that the deregulated transcription factors may play a role in modulating the expression profiles in senescing cells. To test this, the promoter regions of the genes that were differentially expressed were searched for TFBS recognized by the differentially expressed transcription factors. For this, only transcription factors with binding sites that had less than 1,000 possible variants of their cognate binding motif were considered. Transcription factors were ranked according to how many potential target genes their expression levels correlated with and the overall enrichment of their TFBS within promoters of differentially expressed genes when compared to all promoters was calculated. None of the TFBS of the differentially expressed transcription factors were overrepresented within the promoters of the differentially expressed genes (data not shown).

Senescence correlates with reduced SUV39H1 expression and H3K9 trimethylation

The results of the differential gene expression analysis further showed that, when comparing PD 47 or PD 54 to PD 38 cultures, 2.3% and 2.7%, respectively, of the affected genes were involved in epigenetic regulation (Fig. 1C). Among these, SUV39H1, a histone methyltransferase that specifically methylates H3K9 and was previously associated with functions in aging or senescence (S4), was downregulated in senescent cells (PD 54), as confirmed by Western blot analysis (Fig. 3). This downregulation corresponded with significantly reduced H3K9 trimethylation and a trend towards increased H3K9 acetylation (Fig. 3). The loss of H3K9me3, a heterochromatin mark, suggests a global loss of heterochromatin in senescent cells. This may affect senescence through the induction of gene expression changes or genomic instability, and may thus play a causal role in the establishment of senescence.

Figure 3. Age-dependent downregulation of SUV39H1 correlates with a reduction in H3K9me3 levels.

Representative Western blots and bar graphs showing the signal quantifications. Averages of three samples ± SD. Expression levels were normalized to the expression in PD 38 cells.

Reduced levels of SUV39H1 and H3K9me3 correlate with satellite expression

Since SUV39H1-mediated H3K9 trimethylation is important for heterochromatin formation in pericentric satellite regions and, thus, for genomic stability [31, 32], we hypothesized that the downregulation of SUV39H1 and the reduction of H3K9 trimethylation levels may contribute to the senescence-dependent loss of heterochromatin, resulting in genomic instability. In order to test this, we monitored the protein levels of DNA damage checkpoint regulators. This showed that CHK1 and CHK2 protein levels, as well as their phosphorylated forms, were lower in PD 54 cultures when compared to PD 38 and PD 47 cultures (Fig. 4). This is in line with the observed down-regulation of numerous transcripts involved in cell cycle regulation in general (S3).

Figure 4. DNA damage checkpoint regulators are downregulated in senescent cells.

Representative Western blot images and bar graphs showing the quantification of the band intensities. Averages of three biological replicates ± SD.

Next, we examined whether the reduced SUV39H1 expression in senescent cells was associated with heterochromatin relaxation in pericentric satellite regions. The analysis of the transcript levels derived from different satellite regions showed a trend towards increased expression with the rising PD level of the cell cultures (Fig. 5A). This further correlated with the reduced amount of trimethylated H3K9 in satellite regions and in transposon sequences (Fig. 5B), as determined by ChIP. Therefore, the reduced SUV39H1 expression is associated with increased genomic instability through the loss of the H3K9me3 heterochromatin mark in regions of constitutive heterochromatin.

Figure 5. Senescence-dependent increase in satellite expression correlates with the loss of H3K9 trimethylation from those sequences.

(A) Transcript levels of SUV39H1 and satellites normalized to HPRT and YWHAZ and to transcript levels in PD 38. (B) Bars represent averages from three biological replicates, error bars show the error progression of SDs.

Reduced SUV39H1 expression and H3K9me3 level during senescence may affect gene expression

In addition to protecting the genome integrity, H3K9 trimethylation is also important for the transcriptional repression of protein-coding genes. For instance, RB recruits SUV39H1 to its target promoters to mediate transcriptional repression [33] and may therefore limit the expression of genes that are required for the active cell cycle. On the other hand, SUV39H1-mediated H3K9 trimethylation is involved in the silencing of the p21 promoter [34]; thus, the loss of H3K9 trimethylation in the p21 promoter results in p21 expression associated with senescence. Therefore, we examined whether the altered H3K9me3 distribution patterns across the genome may contribute to senescence-dependent changes in gene expression. p21 protein levels were increased in senescent cells and correlated with the reduced expression levels of SUV39H1 (Fig. 6). Further, H3K9me3 was less abundant in the promoter region of IL6 in senescent cells when compared to dividing cells (Fig. 5B), as determined by ChIP, suggesting that reduced SUV39H1 expression levels affect the gene expression profiles of senescent cells.

Figure 6. Downregulation of SUV39H1 affects gene expression profiles.

Western blot images and bar graphs showing the quantification of band intensities. Averages from three samples ± SD.

SUV39H1 inhibition is more toxic for dividing than for senescent cultures

Since SUV39H1 downregulation contributes to increased genomic instability as well as senescence-associated gene expression, we hypothesized that SUV39H1 may play a causal role in the establishment of senescence. If so, the inhibition of SUV39H1 in dividing cells may induce senescence. In order to test this, we treated cells at different PD levels with chaetocin, a specific inhibitor of SUV39H1 [35].

First, we tested the cytotoxicity of increasing concentrations of chaetocin in the cells for all three PD levels, and found that cell cultures of all senescence states maintained a high level of viability when treated with 5 or 10 nM chaetocin and decreased rapidly at higher concentrations (Fig. 7A). Interestingly, the PD 54 cells, which express lower levels of SUV39H1 (Fig. 3), were more tolerant to higher concentrations of chaetocin, as seen by their viability at 48 h and 96 h following chaetocin treatment. In addition to a decrease in viability, increasing concentrations of chaetocin induced greater senescence in PD 47 cells (Fig. 7B).

Figure 7. Chaetocin is more cytotoxic and induces senescence in low PD cultures.

(A) Cell viability after treatment with different concentrations (5 nM, 10 nM, 25 nM, 50 nM, 75 nM, 100 nM, or 200 nM) of chaetocin as determined by the MTT assay. Averages of measurements from three different cultures ± SD. (B) SA-β-GAL staining of PD 47 cultures treated with 0 nM, 5 nM, 10 nM, and 25 nM of chaetocin. Pictures were taken at 10× magnification.

SUV39H1 overexpression in senescent cells induces cell division

Since treatment with increasing concentrations of chaetocin not only affected cell viability but also increasingly induced senescence in the exposed cells (Fig. 7B), we tested how the inhibition of chaetocin in PD 38 cells or the over-expression of SUV39H1 in PD 54 cells affected cell division. For this, PD 38 cells were treated with DMSO or 10 nM chaetocin, while PD 54 cells were transfected with pCMV6-SUV39H1. Chaetocin treatment of PD 38 cells resulted in a reduction of SUV39H1 transcript levels (Fig. 8A) and in a slight decrease in the number of cells in the S phase, which was not significant due to a high variation between the samples (Fig. 8B). On the other hand, the overexpression of SUV39H1 in PD 54 cells resulted in increased SUV39H1 transcript levels (Fig. 8A) and in a significant increase in the amount of cells in the S phase, with a corresponding significant decrease in the number of cells in the G1 phase (Fig. 8B).

Figure 8. Modification of SUV39H1 expression levels affects cell cycle distribution.

(A) SUV39H1 transcript levels normalized to PD 38 control. Averages of three samples ± error progression of SDs. (B) Cell cycle distribution. Averages of three samples ± SD.

Discussion

The cell cultures used herein were selected to show increasing PD levels and an increasing senescence ratio, along with reduced proliferation. The increasing senescence ratio was also associated with a higher number of cells with G2 DNA content. This is in line with previous reports which show that a large fraction of senescent cells exhibit polyploidy and arrest in the G2 phase of the cell cycle [26, 36].

The comparison of the gene expression profiles of three cultures with different senescence states (PD 38, PD 47, and PD 54) further supported the observations that PD 54 cultures contained significantly more senescent and less proliferating cells than the younger cultures; this was observed by the high number of genes involved in cell cycle regulation and aging or senescence affected by differential expression, thus supporting the validity of the model system.

In order to elucidate the underlying mechanisms involved, the gene expression profile of senescent cells was compared to that of young cells. The functional classification of genes that were differentially expressed between PD 47 and PD 38 as well as between PD 54 and PD 38 indicated that cell signalling and transcriptional and epigenetic regulation are affected by expression changes early on during the establishment of senescence (Fig. 1). Further, the regulatory network analysis that was performed using RENATO software connected the deregulation of 295 genes to transcriptional regulation by E2F1. E2F1, E2F2 and E2F3 are transcriptional activators, which are involved in the regulation of G1/S progression and DNA replication [28]. While all of the E2F transcription factors recognize the E2F recognition site in the promoter regions, their target specificity is thought to depend on their interaction with transcription co-activators or co-repressors, as well as on the presence of other binding motifs within the target genes [37-39]. While we did not observe any change in the expression levels of E2F1, E2F2 was downregulated in senescent cells. As E2F1 and E2F2 both recognize the E2F recognition site used to screen for target genes, E2F2 may at least partially be involved in the regulation of the expression of the network associated with E2F1. Thus, the senescence-associated downregulation of E2F2 may play a role in the downregulation of genes involved in the G1/S progression and thus promote the G1 cell cycle arrest and the establishment of senescence. An involvement of E2F2 in the establishment senescence was previously shown in T cells, where E2F2 was shown to act as a transcriptional repressor to result in the inactivation of cell cycle genes and thus the promotion of the transition into the G0 phase of the cell cycle [40]. Further, senescence-associated heterochromatin formation was shown to be targeted to E2F target promoters by Rb [19].

The RENATO analysis also showed a significant enrichment of NF-YA targets among the differentially expressed genes when comparing PD 38 and PD 54. NF-YA also regulates the expression of genes involved in the G1/S transition, and has been previously shown to exhibit a decline in protein levels without a change in transcript level with increasing senescence in IMR90 cells [41]. In addition, E2F transcription factors have been shown to cooperate with other transcription factors, including NF-Y, to mediate the expression of cell cycle genes [42]. Thus, E2F2 and NF-Y may cooperate to mediate the G1 cell cycle arrest at the gene expression level.

Further analysis of the transcription factors that were deregulated during senescence and the correlation of their expression changes with those of their predicted target genes, implicated additional transcription factors that may be involved in the regulation of the senescence-associated gene expression profile. However, their TFBS were not enriched in the promoters of the differentially expressed genes when compared to all promoters. Thus, our findings and previous reports [40, 41, 43] support the important role of changes in transcriptional regulation in the establishment of senescence, in particular through the repression of cell cycle regulators.

In addition to changes in transcriptional regulation, the gene expression profiling data also indicated the deregulation of genes involved in the epigenetic regulation of senescent cells, such as SUV39H1, which was downregulated in senescent cells. This correlated with reduced global levels of H3K9 trimethylation (Fig. 3), site-specific reduction of H3K9me3 abundance in the promoter region of IL6 and in regions of repetitive DNA sequences and corresponding transcription of satellite transcripts (Fig. 5), and with the increased expression of p21 (Fig. 6). This is in line with previous reports describing an important role of SUV39H1 in heterochromatin formation in pericentric satellite regions [31, 32, 44]. Additionally, such a senescence-dependent loss of constitutive heterochromatin has been previously described through the mapping of open chromatin regions by formaldehyde assisted isolation of regulatory elements in human diploid fibroblasts [45]. However, here we present the first evidence that the down-regulation of SUV39H1 in senescent human diploid fibroblasts contributes to heterochromatin relaxation in pericentric satellite regions and thereby contributes to genomic instability. Further, a function of SUV39H1 in the altered regulation of gene expression has also been described. SUV39H1 has been shown to silence S phase genes in terminally differentiating cells in cooperation with E2F/RB [46]. On the other hand, SUV39H1 also plays a role in the silencing of the p21 promoter [34] and thus the loss of H3K9 trimethylation in the p21 promoter results in p21 expression associated with senescence. At first sight, these results may be contradictory, as some promoter regions are specifically targeted by SUV39H1 during senescence and in some promoter regions SUV39H1 is specifically lost. This may be due to the specific recruitment of SUV39H1 by transcription factors [46, 47], and may therefore depend on altered expression or activity of transcriptional programs. Additionally, the specific recruitment of SUV39H1 by transcription factors may contribute to the recruitment of the more limited pool of SUV39H1 away from the DNA regions that it is constitutively associated with. Nevertheless, this would need further investigation. Additionally, it would be important to analyze the roles of other histone H3 acetylation in cellular senescence, since recent reports show that stress-induced acetylation of H3 may regulate p21 transcription [48].

The findings from previous reports [32, 49, 50] along with our observations that reduced SUV39H1 expression and reduced H3K9 trimethylation result in genomic instability and altered gene expression, which may both independently trigger senescence (Fig. 9), suggest that SUV39H1 may have a central function in the establishment of senescence. In line with this, PD 38 and PD 47 cells were significantly less tolerant to high concentrations (more than 25 nM) of chaetocin, a specific SUV39H1 inhibitor, when compared to PD 54 cells (Fig. 7). This may be due to the already reduced expression levels of SUV39H1 in PD 54 cells, suggesting that the cytotoxicity of chaetocin partially depends on the presence of its target SUV39H1. Further, the surviving cells in PD 47 cultures treated with increasing concentrations of chaetocin became senescent (Fig. 7B), suggesting that the inhibition of SUV39H1 was sufficient to induce senescence in low PD cells. Additionally, the inhibition of SUV39H1 in PD 38 cells resulted in a decrease in the amount of cells in the S phase, whereas the overexpression of SUV39H1 in PD 54 cells induced cell division (Fig. 8). These results support the important role of SUV39H1 in the regulation of the transition between cell division and senescence. In addition to our results, previous reports have described several functions of SUV39H1 that underline its importance in cell division such as its role in chromatin organization at centromeres during cell division [51], its role in the organization of the nuclear architecture [52], the inhibition of cellular differentiation programs in transgenic Suv39h1 over-expressing mice [49], and the fact that suv39h1/2 knockout mice suffered from reduced viability, genomic instability, and susceptibility to cancer [32]. While a role for SUV39H1 in the establishment of heterochromatin foci has been described [50], herein we suggest that, during the establishment of replicative senescence, the downregulation of SUV39H1 might provide a switch that alters the chromatin structure from a conformation that promotes cell division to one that promotes cell cycle arrest (Fig. 9). Support for such a theory can be found in a recent study showing that the relaxation of satellite heterochromatin is an early event in the establishment of senescence [53].

Figure 9. Model for the role of SUV39H1 down-regulation in the establishment of senescence.

Green ellipses represent the amount of SUV39H1 present in a cell, black lines represent DNA and red circles represent H3K9me3. Bent arrows indicate transcriptional activity.

However, further studies are needed to elucidate how this downregulation of SUV39H1 is initiated and whether it is a gradual process or an acute switch from one state to the other. Moreover, more studies are needed to dissect the roles of SUV39H1 in aging and replicative senescence. A recent study by Liu et al. (2013) reported that Zmpste24(-/-)/Suv39h1(-/-) mice had a longer maximum lifespan than Zmpste24(-/-) mice – 29 weeks as compared to 40 weeks [54]. Interestingly, Zmpste24 deficiency was shown to be associated with accumulation of unrepaired DNA damage (similar to the one observed in senescent cells) and compromised recruitment of checkpoint and DNA repair proteins to damage sites [55]. Therefore, since Suv39h1 downregulation was also shown to be beneficial for heterochromatin DNA repair [56], it is plausible that Suv39h1 knock-out in Zmpste24(-/-) mice results in slightly more efficient DNA repair and extended lifespan. Notwithstanding, these results may not directly relate to the function of Suv39h1 in replicative senescence. Indeed, it is certainly plausible that the SUV39H1 down-regulation may occur due to the accumulation of unrepaired DNA damage and may initially help the cells repair some of the damage, however, this may be followed by increased genomic instability due to de-heterochromatinization of repetitive DNA sequence elements and thereby contribute to the establishment of senescence.

In summary, the present study has shown that replicative senescence in WI-38 cells is associated with major changes to the gene expression profile. Some of these changes may be caused by altered transcriptional regulation. In addition, we describe a role for the senescence-associated downregulation of SUV39H1 in the loss of heterochromatin in satellite regions, as well as in the promoters of protein coding genes. These changes in chromatin structure may promote the induction of senescence and, in line with this the overexpression of SUV39H1 in senescent cells, induces cell division, whereas the inhibition of SUV39H1 in dividing cells inhibits cell division. Therefore, we suggest that SUV39H1 functions as a switch by maintaining a chromatin conformation that is favourable to cell division as long as it is expressed.

Acknowledgments

We thank Rommy Rodriguez-Juarez, Jody Filkowski, Julian St. Hilaire, Rebecca Pater, and Hannah Dyer for their technical support. This work was supported by graduate studentships from the Alberta Cancer Foundation (ACF) and Alberta Innovates – Health Solutions (AI-HS) to Corinne Sidler and Grants from the US Department of Energy – Low Dose program (DoE), National Sciences and Engineering Research Council of Canada (NSERC), and Canadian Institutes of Health Research (CIHR) to Olga Kovalchuk.

Conflicts of Interest

Authors declare no conflict of interests.

References

• 1. Yang G, Rosen DG, Zhang Z, Bast RC Jr., Mills GB, Colacino JA, Mercado-Uribe I, Liu J. The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesi. Proc Natl Acad Sci U S A. 2006; 103:16472-16477. [PubMed]
• 2. Effros RB. From Hayflick to Walford: the role of T cell replicative senescence in human aging. Exp Gerontol. 2004; 39:885-890. [PubMed]
• 3. Mackall CL, Bare CV, Granger LA, Sharrow SO, Titus JA, Gress RE. Thymic-independent T cell regeneration occurs via antigen-driven expansion of peripheral T cells resulting in a repertoire that is limited in diversity and prone to skewing. J Immunol. 1996; 156:4609-4616. [PubMed]
• 4. Goodwin K, Viboud C, Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine. 2006; 24:1159-1169. [PubMed]
• 5. Krishnamurthy J, Ramsey MR, Ligon KL, Torrice C, Koh A, Bonner-Weir S, Sharpless NE. p16INK4a induces an age-dependent decline in islet regenerative potential. Nature. 2006; 443:453-457. [PubMed]
• 6. Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, Weinberg RA. Creation of human tumour cells with defined genetic elements. Nature. 1999; 400:6743 464-468. [PubMed]
• 7. Hayflick L and Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res. 1961; 25:585-621. [PubMed]
• 8. Hayflick L. The Limited in Vitro Lifetime of Human Diploid Cell Strains. Exp Cell Res. 1965; 37:614-636. [PubMed]
• 9. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A. 1995; 92:9363-9367. [PubMed]
• 10. Rohme D. Evidence for a relationship between longevity of mammalian species and life spans of normal fibroblasts in vitro and erythrocytes in vivo. Proc Natl Acad Sci U S A. 1981; 78:5009-5013. [PubMed]
• 11. Martin GM, Sprague CA, Epstein CJ. Replicative life-span of cultivated human cells. Effects of donor's age, tissue, and genotype. Lab Invest. 1970; 23:86-92..
• 12. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature. 1990; 345:458-460. [PubMed]
• 13. Sfeir A and de Lange T. Removal of shelterin reveals the telomere end-protection problem. Science. 2012; 336:593-597. [PubMed]
• 14. Atadja P, Wong H, Garkavtsev I, Veillette C, Riabowol K. Increased activity of p53 in senescing fibroblasts. Proc Natl Acad Sci U S A. 1995; 92:8348-8352. [PubMed]
• 15. Vaziri H and Benchimol S. From telomere loss to p53 induction and activation of a DNA-damage pathway at senescence: the telomere loss/DNA damage model of cell aging. Exp Gerontol. 1996; 31:295-301. [PubMed]
• 16. Sedelnikova OA, Horikawa I, Zimonjic DB, Popescu NC, Bonner WM, Barrett JC. Senescing human cells and ageing mice accumulate DNA lesions with unrepairable double-strand breaks. Nat Cell Biol. 2004; 6:168-170. [PubMed]
• 17. Sohal RS and Weindruch R. Oxidative stress, caloric restriction, and aging. Science. 1996; 273:59-63. [PubMed]
• 18. Chitikova ZV, Gordeev SA, Bykova TV, Zubova SG, Pospelov VA, Pospelova TV. Sustained activation of DNA damage response in irradiated apoptosis-resistant cells induces reversible senescence associated with mTOR downregulation and expression of stem cell markers. Cell Cycle. 2014; 13:1424-1439. [PubMed]
• 19. Narita M, Nunez S, Heard E, Lin AW, Hearn SA, Spector DL, Hannon GJ, Lowe SW. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell. 2003; 113:703-716. [PubMed]
• 20. Stein GH, Beeson M, Gordon L. Failure to phosphorylate the retinoblastoma gene product in senescent human fibroblasts. Science. 1990; 249:666-669. [PubMed]
• 21. Barascu A, Le Chalony C, Pennarun G, Genet D, Imam N, Lopez B, Bertrand P. Oxidative stress induces an ATM-independent senescence pathway through p38 MAPK-mediated lamin B1 accumulation. EMBO J. 2012; 31:1080-1094. [PubMed]
• 22. Moskalev AA, Aliper AM, Smit-McBride Z, Buzdin A, Zhavoronkov A. Genetics and epigenetics of aging and longevity. Cell Cycle. 2014; 13:1063-1077. [PubMed]
• 23. O'Sullivan RJ and Karlseder J. The great unravelling: chromatin as a modulator of the aging process. Trends Biochem Sci. 2012; 37:466-476. [PubMed]
• 24. Feser J and Tyler J. Chromatin structure as a mediator of aging. FEBS Lett. 2011; 585:13 2041-2048. [PubMed]
• 25. Sedivy JM, Banumathy G, Adams PD. Aging by epigenetics--a consequence of chromatin damage? Exp Cell Res. 2008; 314:1909-1917. [PubMed]
• 26. Sherwood SW, Rush D, Ellsworth JL, Schimke RT. Defining cellular senescence in IMR-90 cells: a flow cytometric analysis. Proc Natl Acad Sci U S A. 1988; 85:9086-9090. [PubMed]
• 27. de Magalhaes JP, Curado J, Church GM. Meta-analysis of age-related gene expression profiles identifies common signatures of aging. Bioinformatics. 2009; 25:875-881. [PubMed]
• 28. Wu L, Timmers C, Maiti B, Saavedra HI, Sang L, Chong GT, Nuckolls F, Giangrande P, Wright FA, Field SJ, Greenberg ME, Orkin S, Nevins JR, et al. The E2F1-3 transcription factors are essential for cellular proliferation. Nature. 2001; 414:457-462. [PubMed]
• 29. Chong JL, Wenzel PL, Saenz-Robles MT, Nair V, Ferrey A, Hagan JP, Gomez YM, Sharma N, Chen HZ, Ouseph M, Wang SH, Trikha P, Culp B, et al. E2f1-3 switch from activators in progenitor cells to repressors in differentiating cells. Nature. 2009; 462:930-934. [PubMed]
• 30. DeGregori J, Leone G, Miron A, Jakoi L, Nevins JR. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc Natl Acad Sci U S A. 1997; 94:7245-7250. [PubMed]
• 31. Lehnertz B, Ueda Y, Derijck AA, Braunschweig U, Perez-Burgos L, Kubicek S, Chen T, Li E, Jenuwein T, Peters AH. Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin. Curr Biol. 2003; 13:1192-1200. [PubMed]
• 32. Peters AH, O'Carroll D, Scherthan H, Mechtler K, Sauer S, Schofer C, Weipoltshammer K, Pagani M, Lachner M, Kohlmaier A, Opravil S, Doyle M, Sibilia M, et al. Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability. Cell. 2001; 107:323-337. [PubMed]
• 33. Nielsen SJ, Schneider R, Bauer UM, Bannister AJ, Morrison A, O'Carroll D, Firestein R, Cleary M, Jenuwein T, Herrera RE, Kouzarides T. Rb targets histone H3 methylation and HP1 to promoters. Nature. 2001; 412:561-565. [PubMed]
• 34. Cherrier T, Suzanne S, Redel L, Calao M, Marban C, Samah B, Mukerjee R, Schwartz C, Gras G, Sawaya BE, Zeichner SL, Aunis D, Van Lint C, et al. p21(WAF1) gene promoter is epigenetically silenced by CTIP2 and SUV39H1. Oncogene. 2009; 28:3380-3389. [PubMed]
• 35. Greiner D, Bonaldi T, Eskeland R, Roemer E, Imhof A. Identification of a specific inhibitor of the histone methyltransferase SU(VAR)3-9. Nat Chem Biol. 2005; 1:143-145. [PubMed]
• 36. Mao Z, Ke Z, Gorbunova V, Seluanov A. Replicatively senescent cells are arrested in G1 and G2 phases. Aging (Albany NY). 2012; 4:431-435. [PubMed]
• 37. Freedman JA, Chang JT, Jakoi L, Nevins JR. A combinatorial mechanism for determining the specificity of E2F activation and repression. Oncogene. 2009; 28:2873-2881. [PubMed]
• 38. Schlisio S, Halperin T, Vidal M, Nevins JR. Interaction of YY1 with E2Fs, mediated by RYBP, provides a mechanism for specificity of E2F function. EMBO J. 2002; 21:5775-5786. [PubMed]
• 39. Giangrande PH, Zhu W, Rempel RE, Laakso N, Nevins JR. Combinatorial gene control involving E2F and E Box family members. EMBO J. 2004; 23:1336-1347. [PubMed]
• 40. Infante A, Laresgoiti U, Fernandez-Rueda J, Fullaondo A, Galan J, Diaz-Uriarte R, Malumbres M, Field SJ, Zubiaga AM. E2F2 represses cell cycle regulators to maintain quiescence. Cell Cycle. 2008; 7:3915-3927. [PubMed]
• 41. Matuoka K and Chen KY. Possible role of subunit A of nuclear factor Y (NF-YA) in normal human diploid fibroblasts during senescence. Biogerontology. 2000; 1:261-271. [PubMed]
• 42. van Ginkel PR, Hsiao KM, Schjerven H, Farnham PJ. E2F-mediated growth regulation requires transcription factor cooperation. J Biol Chem. 1997; 272:18367-18374. [PubMed]
• 43. Matuoka K and Chen KY. Transcriptional regulation of cellular ageing by the CCAAT box-binding factor CBF/NF-Y. Ageing Res Rev. 2002; 1:639-651. [PubMed]
• 44. Wang D, Zhou J, Liu X, Lu D, Shen C, Du Y, Wei FZ, Song B, Lu X, Yu Y, Wang L, Zhao Y, Wang H, et al. Methylation of SUV39H1 by SET7/9 results in heterochromatin relaxation and genome instability. Proc Natl Acad Sci U S A. 2013; 110:5516-5521. [PubMed]
• 45. De Cecco M, Criscione SW, Peckham EJ, Hillenmeyer S, Hamm EA, Manivannan J, Peterson AL, Kreiling JA, Neretti N, Sedivy JM. Genomes of replicatively senescent cells undergo global epigenetic changes leading to gene silencing and activation of transposable elements. Aging Cell. 2013; 12:247-256. [PubMed]
• 46. Ait-Si-Ali S, Guasconi V, Fritsch L, Yahi H, Sekhri R, Naguibneva I, Robin P, Cabon F, Polesskaya A, Harel-Bellan A. A Suv39h-dependent mechanism for silencing S-phase genes in differentiating but not in cycling cells. EMBO J. 2004; 23:605-615. [PubMed]
• 47. Lomberk G, Mathison AJ, Grzenda A, Seo S, DeMars CJ, Rizvi S, Bonilla-Velez J, Calvo E, Fernandez-Zapico ME, Iovanna J, Buttar NS, Urrutia R. Sequence-specific recruitment of heterochromatin protein 1 via interaction with Kruppel-like factor 11, a human transcription factor involved in tumor suppression and metabolic diseases. J Biol Chem. 2012; 287:13026-13039. [PubMed]
• 48. Love IM, Sekaric P, Shi D, Grossman SR, Androphy EJ. The histone acetyltransferase PCAF regulates p21 transcription through stress-induced acetylation of histone H3. Cell Cycle. 2012; 11:2458-2466. [PubMed]
• 49. Czvitkovich S, Sauer S, Peters AH, Deiner E, Wolf A, Laible G, Opravil S, Beug H, Jenuwein T. Over-expression of the SUV39H1 histone methyltransferase induces altered proliferation and differentiation in transgenic mice. Mech Dev. 2001; 107:141-153. [PubMed]
• 50. Bandyopadhyay D, Curry JL, Lin Q, Richards HW, Chen D, Hornsby PJ, Timchenko NA, Medrano EE. Dynamic assembly of chromatin complexes during cellular senescence: implications for the growth arrest of human melanocytic nevi. Aging Cell. 2007; 6:577-591. [PubMed]
• 51. Aagaard L, Schmid M, Warburton P, Jenuwein T. Mitotic phosphorylation of SUV39H1, a novel component of active centromeres, coincides with transient accumulation at mammalian centromeres. J Cell Sci. 2000; 113:817-829. [PubMed]
• 52. Uhlirova R, Horakova AH, Galiova G, Legartova S, Matula P, Fojtova M, Varecha M, Amrichova J, Vondracek J, Kozubek S, Bartova E. SUV39h- and A-type lamin-dependent telomere nuclear rearrangement. J Cell Biochem. 2010; 109:915-926. [PubMed]
• 53. Swanson EC, Manning B, Zhang H, Lawrence JB. Higher-order unfolding of satellite heterochromatin is a consistent and early event in cell senescence. J Cell Biol. 2013; 203:929-942. [PubMed]
• 54. Liu B, Wang Z, Zhang L, Ghosh S, Zheng H, Zhou Z. Depleting the methyltransferase Suv39h1 improves DNA repair and extends lifespan in a progeria mouse model. Nat Commun. 2013; 4:1868 [PubMed]
• 55. Liu B, Wang J, Chan KM, Tjia WM, Deng W, Guan X, Huang JD, Li KM, Chau PY, Chen DJ, Pei D, Pendas AM, Cadinanos J, et al. Genomic instability in laminopathy-based premature aging. Nat Med. 2005; 11:780-785. [PubMed]
• 56. Zheng H, Chen L, Pledger WJ, Fang J, Chen J. p53 promotes repair of heterochromatin DNA by regulating JMJD2b and SUV39H1 expression. Oncogene. 2014; 33:734-744. [PubMed]
• 57. Debacq-Chainiaux F, Erusalimsky JD, Campisi J, Toussaint O. Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo. Nat Protoc. 2009; 4:1798-1806. [PubMed]
• 58. Reimand J, Kull M, Peterson H, Hansen J, Vilo J. g:Profiler--a web-based toolset for functional profiling of gene lists from large-scale experiments. Nucleic Acids Res. 2007; 35:Web Server issue W193-200. [PubMed]
• 59. Reimand J, Arak T, Vilo J. g:Profiler--a web server for functional interpretation of gene lists (2011 update). Nucleic Acids Res. 2011; 39:Web Server issue W307-315. [PubMed]
• 60. Bleda M, Medina I, Alonso R, De Maria A, Salavert F, Dopazo J. Inferring the regulatory network behind a gene expression experiment. Nucleic Acids Res. 2012; 40:Web Server issue W168-172. [PubMed]
• 61. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009; 4:44-57. [PubMed]
• 62. Safran M, Dalah I, Alexander J, Rosen N, Iny Stein T, Shmoish M, Nativ N, Bahir I, Doniger T, Krug H, Sirota-Madi A, Olender T, Golan Y, et al. GeneCards Version 3: the human gene integrator. Database (Oxford). 2010; 2010:baq020 [PubMed]
• 63. Flicek P, Aken BL, Ballester B, Beal K, Bragin E, Brent S, Chen Y, Clapham P, Coates G, Fairley S, Fitzgerald S, Fernandez-Banet J, Gordon L, et al. Ensembl's 10th year. Nucleic Acids Res. 2010; 38:Database issue D557-562. [PubMed]
• 64. Yan T, Yoo D, Berardini TZ, Mueller LA, Weems DC, Weng S, Cherry JM, Rhee SY. PatMatch: a program for finding patterns in peptide and nucleotide sequences. Nucleic Acids Res. 2005; 33:Web Server issue W262-266. [PubMed]
• 65. Lamesch P, Berardini TZ, Li D, Swarbreck D, Wilks C, Sasidharan R, Muller R, Dreher K, Alexander DL, Garcia-Hernandez M, Karthikeyan AS, Lee CH, Nelson WD, et al. The Arabidopsis Information Resource (TAIR): improved gene annotation and new tools. Nucleic Acids Res. 2012; 40:Database issue D1202-1210. [PubMed]
• 66. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002; 3:RESEARCH0034 [PubMed]
• 67. Koturbash I, Boyko A, Rodriguez-Juarez R, McDonald RJ, Tryndyak VP, Kovalchuk I, Pogribny IP, Kovalchuk O. Role of epigenetic effectors in maintenance of the long-term persistent bystander effect in spleen in vivo. Carcinogenesis. 2007; 28:1831-1838. [PubMed]
• 68. Nelson JD, Denisenko O, Bomsztyk K. Protocol for the fast chromatin immunoprecipitation (ChIP) method. Nat Protoc. 2006; 1:179-185. [PubMed]